Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (191-200 of 243) with videos related to

Pageof 25
Sort By:
Viruses|July 29, 2023
Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIVMajdouline El Moussaoui, Salomé Desmecht, Nicolas Lambert, et al.
Journal of Hematology & Oncology|October 25, 2021
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsLorenzo Canti, Stéphanie Humblet-Baron, Isabelle Desombere, et al.
British Journal of Haematology|October 2, 2009
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationIrit Avivi, Silvia Montoto, Carme Canals, et al.
The Journal of Infection|September 12, 2022
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIVMajdouline El Moussaoui, Salomé Desmecht, Aleksandr Tashkeev, et al.
Ejhaem|August 25, 2020
Sickle cell disease and COVID-19: Atypical presentations and favorable outcomesMarie-Agnès Azerad, Firas Bayoudh, Thierry Weber, et al.
Acta Neurologica Belgica|March 15, 2018
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosisGuy Laureys, Barbara Willekens, Ludo Vanopdenbosch, et al.
European Journal of Haematology|January 17, 2013
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
British Journal of Haematology|February 1, 2021
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort studyAlienor Xhaard, Constance Xhaard, Maud D'Aveni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2014
Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie CellulaireGandhi Damaj, Mohammad Mohty, Marie Robin, et al.
Bone Marrow Transplantation|July 6, 2026
ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TCLudovic Jondreville, Stéphanie Nguyen, Patrice Ceballos, et al.
Pageof 25

Showing results (191-200 of 243) with videos related to

Sort By:
Pageof 25
Viruses|July 29, 2023
Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIVMajdouline El Moussaoui, Salomé Desmecht, Nicolas Lambert, et al.
Journal of Hematology & Oncology|October 25, 2021
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsLorenzo Canti, Stéphanie Humblet-Baron, Isabelle Desombere, et al.
British Journal of Haematology|October 2, 2009
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationIrit Avivi, Silvia Montoto, Carme Canals, et al.
The Journal of Infection|September 12, 2022
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIVMajdouline El Moussaoui, Salomé Desmecht, Aleksandr Tashkeev, et al.
Ejhaem|August 25, 2020
Sickle cell disease and COVID-19: Atypical presentations and favorable outcomesMarie-Agnès Azerad, Firas Bayoudh, Thierry Weber, et al.
Acta Neurologica Belgica|March 15, 2018
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosisGuy Laureys, Barbara Willekens, Ludo Vanopdenbosch, et al.
European Journal of Haematology|January 17, 2013
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
British Journal of Haematology|February 1, 2021
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort studyAlienor Xhaard, Constance Xhaard, Maud D'Aveni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2014
Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie CellulaireGandhi Damaj, Mohammad Mohty, Marie Robin, et al.
Bone Marrow Transplantation|July 6, 2026
ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TCLudovic Jondreville, Stéphanie Nguyen, Patrice Ceballos, et al.
Pageof 25